Occurrence and progression of dementia in a community population aged 75 years and older: Relationship of antihypertensive medication use

Archives of Neurology

Volumn 56, Issue 8, 1999, Pages 991-996

  Guo, Zhenchao ^a   Fratiglioni, Laura ^a   Zhu, Li ^a   Fastbom, Johan ^a   Winblad, Bengt ^a   Viitanen, Matti ^a  

^a STOCKHOLM GERONTOLOGY RESEARCH CENTER   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIURETIC AGENT;

AGED; ALZHEIMER DISEASE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; COGNITION; COHORT ANALYSIS; DATA ANALYSIS; DEMENTIA; DIURETIC ACTIVITY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIHYPERTENSIVE AGENTS; CATCHMENT AREA (HEALTH); COGNITION DISORDERS; COHORT STUDIES; COMMUNITY HEALTH SERVICES; DISEASE PROGRESSION; DIURETICS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; MALE; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; SEVERITY OF ILLNESS INDEX;

EID: 0032816804     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.56.8.991     Document Type: Article

References (42)

1. Skoog I, Nilsson L, Palmertz B, Andreasson LA, Svanborg A. A population-based study of dementia in 85-year-olds. N Engl J Med. 1993;328:153-158.
2. O'Brien MD. How does cerebrovascular disease cause dementia? Dementia. 1994; 5:133-136.
3. Forette F, Boller F. Hypertension and the risk of dementia in the elderly. Am J Med. 1991;90(suppl 3A):14S-19S.
4. Hachinski V. Preventable senility: a call for action against the vascular dementias. Lancet. 1992;340:645-648.
5. Scheinberg P. Dementia due to vascular disease: a multifactorial disorder. Stroke. 1988;19:1291-1299.
6. Gorelick PB. Status of risk factors for dementia associated with stroke. Stroke. 1997;28:459-463.
7. Roman GC. Senile dementia of the Binswanger type: a vascular form of dementia in the elderly. JAMA. 1987;258:1782-1788.
8. Guo Z, Viitanen M, Fratiglioni L, Winblad B. Blood pressure and dementia in the elderly: epidemiologic perspectives. Biomed Pharmacother. 1997;51:68-73.
9. Geldmacher DS, Whitehouse PJ. Evaluation of dementia. N Engl J Med. 1996; 335:330-336.
10. Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology. 1995;45:1161-1168.
11. Skoog I, Lernfelt B, Landahl S, et al. 15-Year longitudinal study of blood pressure and dementia. Lancet. 1996;347:1141-1145.
12. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer's disease: the Nun Study. JAMA. 1997;277:813-817.
13. Olichney JM, Hansen LA, Hofstetter CR, Grundman M, Katzman R, Thal LJ. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol. 1995;52:702-708.
14. Viitanen M, Guo Z. Are cognitive function and blood pressure related? Drugs Aging. 1997;11:165-169.
15. Prince MJ, Bird AS, Blizard RA, Mann AH. Is the cognitive function of older patients affected by antihypertensive treatment? results from 54 months of the Medical Research Council's trial of hypertension in older adults. BMJ. 1996;312:801-805.
16. Applegate WB, Pressel S, Wittes J, et al. Impact of the treatment of isolated systolic hypertension on behavioral variables: results from the Systolic Hypertension in the Elderly Program. Arch Intern Med. 1994;154:2154-2160.
17. Fratiglioni L, Viitanen M, Bäckman L, Sandman PO, Winblad B. Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. Neuroepidemiology. 1992;11(suppl 1):29-36.
18. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-198.
19. Fratiglioni L, Grut M, Forsell Y, et al. Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology. 1991;41:1886-1892.
20. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology. 1997;48:132-138.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised, Third Edition. Washington, DC: American Psychiatric Association; 1987.
22. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566-572.
23. Forsell Y, Fratiglioni L, Grut M, Viitanen M, Winblad B. Clinical staging of dementia in a population survey: comparison of DSM-III-R and the Washington University Clinical Dementia Rating Scale. Acta Psychiatr Scand. 1992;86:49-54.
24. Wills P, Fastbom J, Claesson CB, Cornelius C, Thorslund M, Winblad B. Use of cardiovascular drugs in an older Swedish population. J Am Geriatr Soc. 1996; 44:54-60.
25. Nordic Council on Medicines. Guidelines for ATC Classification [in Swedish].
26. Uppsala, Sweden: Nordic Council on Medicines; 1985. NLN publication 16. 26. Guo Z, Fratiglioni L, Winblad B, Viitanen M. Blood pressure and performance on the Mini-Mental State Examination in the very old: cross-sectional and longitudinal data from the Kungsholmen Project. Am J Epidemiol. 1997;145:1106-1113.
27. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol. 1997;145:72-80.
28. Davis KL. Future therapeutic approaches to Alzheimer's disease. J Clin Psychiatry. 1998;59(suppl 11):14-16.
29. Kaplan NM, Gifford RW Jr. Choice of initial therapy for hypertension. JAMA. 1996; 275:1577-1580.
30. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis. JAMA. 1997;277:739-745.
31. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report: a review. Stroke. 1995;26:1293-1301.
32. Sparks DL, Scheff W, Liu H, et al. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci. 1995;131: 162-169.
33. Kalaria R. Cerebral vessels in aging and Alzheimer's disease. Pharmacol Ther. 1996;72:193-214.
34. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M. β-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature. 1996;380:168-171.
35. Rosenberg RN. A causal role for amyloid in Alzheimer's disease: the ending of the beginning. Neurology. 1993;43:851-856.
36. Selkoe DJ. Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem. 1996;271:18295-18298.
37. 1-42 induced endothelial toxicity. Brain Res. 1997;762:144-152.
38. Kool MJ, Lustermans FA, Breed JG, et al. The influence of perindopril and the diuretic combination amiloride + hydrochlorothiazide on the vessel wall properties of large arteries in hypertensive patients. J Hypertens. 1985;13:839-848.
39. Kähönen M, Mäkynen H, Arvola P, Wuorela H, Pörsti I. Arterial function after trichlormethiazide therapy in spontaneously hypertensive rats. J Pharmacol Exp Ther. 1995;272:1223-1230.
40. Abrahams Z, Tan LLY, Pang MYM, Abrahams B, Tan MM, Wright JM. Demonstration of an in vitro direct vascular relaxant effect of diuretics in the presence of plasma. J Hypertens. 1996;14:381-388.
41. Guo Z, Viitanen M, Fratiglioni L, Winblad B. Low blood pressure and dementia in elderly people: the Kungsholmen Project. BMJ. 1996;312:805-808.
42. Hogan DB, Ebly EM, Rockwood K. Weight, blood pressure, osmolarity, and glucose levels across various stages of Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord. 1997;8:147-151.